Page last updated: 2024-08-05 15:06:50

bronchoconstrictor agent

A drug which causes a narrowing of the lumen of a bronchus or bronchiole.

ChEBI ID: 50141

Members (7)

MemberDefinitionClass
1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholineA 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has octadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
1-hexadecyl-2-acetyl-glycero-3-phosphocholineA 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has hexadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine
8-epi-prostaglandin f2alphaAn isoprostane that is prostaglandin F2alpha having inverted stereochemistry at the 8-position.8-epi-prostaglandin F2alpha
8-isoprostaglandin e2A prostanoid that is prostaglandin E2 having inverted stereochemistry at the 8-position.8-epi-prostaglandin E2
leukotriene c4A leukotriene that is (5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid in which a glutathionyl group is attached at position 6 via a sulfide linkage.leukotriene C4
leukotriene d4A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R).leukotriene D4
methacholineA quaternary ammonium ion in which the nitrogen is substituted with three methyl groups and a 2-acetoxypropyl group. Parasympathomimetic bronchoconstrictor drug used in clinical diagnosis.methacholine

Research

Studies (12,275)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19902,316 (18.87)18.7374
1990's5,343 (43.53)18.2507
2000's2,853 (23.24)29.6817
2010's1,556 (12.68)24.3611
2020's207 (1.69)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials521 (3.99%)5.53%
Reviews1,097 (8.40%)6.00%
Case Studies71 (0.54%)4.05%
Observational19 (0.15%)0.25%
Other11,357 (86.93%)84.16%

Protein Targets (26)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.668412
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency42.561511
Chain A, CruzipainTrypanosoma cruziPotency39.810711
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency25.118911
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.981111
GLS proteinHomo sapiens (human)Potency2.818411
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency2.238711
regulator of G-protein signaling 4Homo sapiens (human)Potency6.905814

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Canalicular multispecific organic anion transporter 1Rattus norvegicus (Norway rat)IC505.480011
Cysteinyl leukotriene receptor 1Homo sapiens (human)IC500.003822
Cysteinyl leukotriene receptor 1Homo sapiens (human)Ki0.000422
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)Ki0.000311
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)IC500.000711
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)Ki0.000311
Muscarinic acetylcholine receptor M2Homo sapiens (human)IC502.790022
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)IC503.593323
Muscarinic acetylcholine receptor M2Homo sapiens (human)Ki0.059011
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.059011
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)IC500.700011
Muscarinic acetylcholine receptor M4Homo sapiens (human)Ki1.600011
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)Ki1.600011
Platelet-activating factor receptorHomo sapiens (human)IC500.000311
Platelet-activating factor receptorHomo sapiens (human)Ki0.000111

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Cysteinyl leukotriene receptor 1Homo sapiens (human)EC500.021912
Cysteinyl leukotriene receptor 2Homo sapiens (human)EC500.006612
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)EC500.400011
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)EC500.120011
NPYLR7BAedes aegypti (yellow fever mosquito)EC5020.000011

Other Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Canalicular multispecific organic anion transporter 1Rattus norvegicus (Norway rat)Km1.500011